Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption

Journal of the American College of Cardiology

Volumn 39, Issue 4, 2002, Pages 646-652

  Felix, Stephan B ^a   Staudt, Alexander ^a   Landsberger, Martin ^a   Grosse, Yvonne ^a   Stangl, Verena ^b   Spielhagen, Thomas ^b   Wallukat, Gerd ^c   Wernecke, Klaus D ^d   Baumann, Gert ^b   Stangl, Karl ^b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HEART ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MEMBRANE PROTEIN; PROTEIN; PROTEIN A; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DOSE RESPONSE; FLUORESCENCE; HEART DILATATION; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEMODIALYSIS; HEMODYNAMICS; HUMAN; IMMUNOADSORPTION; IMMUNOASSAY; IMMUNOPRECIPITATION; MALE; MUSCLE FIBER CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; AUTOANTIBODIES; CARDIOMYOPATHY, DILATED; HEART; HEMODYNAMIC PROCESSES; HUMANS; IMMUNOGLOBULIN G; IMMUNOSORBENT TECHNIQUES; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; RATS; RATS, WISTAR;

EID: 0037138554     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01794-6     Document Type: Article

References (28)

1. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies
2. Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy: Correlation with disease severity and cardiac autoantibodies
3. Elevated circulating levels of beta-2 microglobulin in patients with idiopathic dilated cardiomyopathy
4. Antibodies to ADP-ATP carrier - An autoantigen in myocarditis and dilated cardiomyopathy - Impair cardiac function
5. Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy
6. Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy
7. 1-adrenoceptor with positive chronotropic effect
8. Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic beta-adrenoceptor function in cultured neonatal rat heart myocytes
9. A synthetic peptide corresponding to the second extracellular loop of the human M2 acetylcholine receptor induces pharmacological and morphological changes in cardiomyocytes by active immunization after 6 months in rabbits
10. Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy
11. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: Three-month results from a randomized study
12. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution
13. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy
14. Myocarditis: The Dallas criteria
15. Soluble substances released from postischemic reperfused rat hearts reduce calcium transient and contractility by blocking the L-type calcium channel
16. 2+, contraction, and potential in cardiac myocytes
17. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
18. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
19. 1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure
20. Myocarditis
21. Advances in the understanding of myocarditis
22. Immunohistochemistry in dilated cardiomyopathy
23. Expression of cell adhesion molecules in dilated cardiomyopathy: Evidence for endothelial activation in inflammatory cardiomyopathy
24. Recent insights into the role of tumor necrosis factor in the failing heart
25. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure
26. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure
27. Controlled trial of intravenous immune globulin in recent-onset cardiomyopathy
28. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: Two-year follow-up results